Financhill
Back

Immunome Stock Predictions

Immunome Stock Forecast

  • Over the next 52 weeks, Immunome has on average historically risen by 43.4% based on the past 3 years of stock performance.
  • Immunome has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is Immunome Stock Undervalued?
    The current Immunome [IMNM] share price is $15.75. The Score for IMNM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • IMNM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Immunome Stock Go Up Next Year?

  • Over the next 52 weeks, Immunome has on average historically risen by 43.4% based on the past 3 years of stock performance.

Immunome Stock Rating

Buy
62
Immunome (IMNM) is a Buy

Is Immunome overpriced?

  • Immunome has risen higher in 2 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

Immunome Stock Price History

Is IMNM stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IMNM is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immunome.com

52-Week Data

52-Week High:
30.96
52-Week Low:
4.50

Prediction Charts

Market Cap:
940.18M
Price in USD:
15.75
Volume:
728.42K
Beta:
1.89

Technical Analysis

SMA50:
21.09
SMA100:
17.99
SMA200:
12.83
52-Wk Change:
209.43%

Stock Predictions

  • Is Immunome stock public?
    Yes, Immunome is a publicly traded company.
  • What is the Immunome stock quote today?
    The Immunome stock price is 15.75 USD today.
  • How to buy Immunome stock online?
    You can buy Immunome shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Apr-16 18.87 18.40 19.07 18.16
Apr-17 18.50 17.38 18.56 17.38
Apr-18 17.34 17.15 17.97 17.15
Apr-19 17.26 15.48 17.60 15.42
Apr-22 16.06 15.28 16.06 15.06
Apr-23 15.32 14.66 15.65 14.64
Apr-24 14.76 14.27 14.92 14.20
Apr-25 14.20 14.26 14.61 13.82
Apr-26 14.28 13.73 14.39 13.70
Apr-29 13.71 13.82 14.15 13.70
Apr-30 14.26 14.07 14.36 13.81
May-1 13.95 14.68 15.26 13.92
May-2 14.79 14.97 15.02 14.39
May-3 15.26 15.75 16.05 15.10

Immunome Earnings

Immunome Earnings Report: Per Share Immunome Earnings Q1 Q2 Q3 and Q4 last year and next year.

Immunome Forecast Revenue Growth

Immunome Stock Analysis: Historical quarterly revenues per share for Immunome and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.98 per share, and a decrease next year of $0.74 per share.

* Immunome stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.